Coffee, caffeine and non-alcoholic fatty liver disease?

Documenti analoghi

• Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease
  di: Hydes, Theresa, et al.
  Pubblicazione: (2020)
• All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study
  di: Kennedy, Oliver J., et al.
  Pubblicazione: (2021)
• Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
  di: Kennedy, Oliver John, et al.
  Pubblicazione: (2017)
• Non‐invasive markers associated with liver fibrosis in non‐alcoholic fatty liver disease
  di: Guha, I N, et al.
  Pubblicazione: (2006)
• Body Composition and Non-alcoholic Fatty Liver Disease
  di: Abenavoli, Ludovico, et al.
  Pubblicazione: (2016)